The long-term goal of our research is to investigate how the intracellular signaling circuitry is wired in response to specific extracellular stimuli, thereby identifying potential therapeutic targets for prevention and treatment of human diseases. In this proposal, we will study the molecular mechanism underlying the IKK signaling network and its pathophysiological implications, using regulation of Bad by IKK in TNF?-induced apoptosis as a molecular probe. Using multifaceted approaches, we uncovered a second signaling pathway of the IKK signaling network, i.e., the IKK-Bad axis. We found that Bad is a novel target of IKK and is also required for TNF?-induced apoptosis in vitro and in vivo. Regulation of Bad by IKK is involved in inhibition of TNF?-induced apoptosis. We hypothesize that in addition to activation of NF-?B, IKK inhibits TNF?-induced apoptosis via inactivation of Bad, i.e., the NF-?B activation and Bad inactivation model. This proposal is novel, as it will study the role of the IKK-Bad axis in apoptosis induced by TNF? and other death stimuli, as well as in necrosis and autophagy, and the underlying mechanism and pathophysiological functions of the regulation in vitro and in vivo. This study will put forward a novel paradigm regarding the IKK signaling network and will provide a better understanding of the biological functions of the IKK signaling network in terms of regulation of cell death, which plays an important role in many human diseases.
The I?B kinase complex (IKK) is activated by a variety of extracellular stimuli, including the pro-inflammatory cytokine tumor necrosis factor (TNF?), and in turn it regulates immune responses, inflammation and cell death. The biological functions of IKK are thought to be mediated by NF-?B. Our finding that IKK inhibits TNF?-induced apoptosis through inactivation of the pro-death Bcl-2 family protein Bad uncovers a second signaling pathway of IKK signaling network, i.e., the IKK-Bad axis, and should shed light on our understanding of molecular mechanism underlying cell death, which deregulation leads to numerous human diseases.
|Yan, Jie; Zhang, Hao; Xiang, Jialing et al. (2018) The BH3-only protein BAD mediates TNF? cytotoxicity despite concurrent activation of IKK and NF-?B in septic shock. Cell Res 28:701-718|
|Zhao, Yu; Lin, Yuting; Zhang, Honghong et al. (2015) Ubl4A is required for insulin-induced Akt plasma membrane translocation through promotion of Arp2/3-dependent actin branching. Proc Natl Acad Sci U S A 112:9644-9|
|Yan, Jie; Xiang, Jialing; Lin, Yutin et al. (2013) Inactivation of BAD by IKK inhibits TNF?-induced apoptosis independently of NF-?B activation. Cell 152:304-15|
|Do-Umehara, Hanh Chi; Chen, Cong; Urich, Daniela et al. (2013) Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-?. Nat Immunol 14:461-9|
|Puckett, Mary C; Goldman, Erinn H; Cockrell, Lisa M et al. (2013) Integration of apoptosis signal-regulating kinase 1-mediated stress signaling with the Akt/protein kinase B-I?B kinase cascade. Mol Cell Biol 33:2252-9|
|Lin, Anning (2011) ATIA: a link between inflammation and hypoxia. Mol Cell 42:557-8|
|Deng, Hongbin; Zhang, Jingpu; Yoon, Taewon et al. (2011) Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells. Int J Biochem Cell Biol 43:409-15|